Serum sestrin 2 levels in patients with uterine leiomyomas

Sadeleştirilmiş öğe sayfası
dc.contributor.authorKabakci, Meric
dc.contributor.authorSelcuki, Nura Fitnat Topbas
dc.contributor.authorAydin, Zelal
dc.contributor.authorBagci, Kubra
dc.contributor.authorKaya, Cihan
dc.contributor.authorBahat, Pinar Yalcin
dc.date.accessioned2025-10-16T15:16:38Z
dc.date.issued2022
dc.identifier.doi10.1080/01443615.2022.2141613
dc.identifier.otherWOS:000880214400001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/6747
dc.publisherTAYLOR \& FRANCIS INC
dc.sourceJOURNAL OF OBSTETRICS AND GYNAECOLOGY
dc.subjectUterine leiomyoma
dc.subjectserum sestrin 2
dc.subjectSESN2
dc.subjectbenign gynecological tumours
dc.subjectcell proliferation
dc.subjectcell differentiation
dc.titleSerum sestrin 2 levels in patients with uterine leiomyomas
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS